Czechia· CZ-0289312
PIOGLITAZON VIATRIS
A pioglitazone product containing pioglitazone hydrochloride, registered in Czechia by Mylan Ireland Limited, Dublin. The same ATC class is registered in 18 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Pioglitazone is registered in 18 of 19 countries.
Countries holding a registration under ATC A10BG03 (pioglitazone), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 10 of them publish a price we can compare per daily dose
Pioglitazone · ATC A10BG03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of pioglitazone costs, country by country.
Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.11 in United States to $1.64 in Switzerland — a ×14 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Pioglitazone · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.64
- ES Spain$1.22
- IT Italy$0.81
- US United States$0.11 (acquisition cost)
The record
At a glance
SÚKL (Czech Republic)- Active substance
- PIOGLITAZONE HYDROCHLORIDE
- Manufacturer
- Mylan Ireland Limited, Dublin
- Country
- Czechia (CZ)
- ATC code
- A10BG03
- ATC class
- Pioglitazone
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
732 interactions on record for pioglitazone.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pioglitazone · interactions on record
732 records
- 11 severe
- 302 moderate
- 63 minor
- 355 info
Most severe, free to view
- ClopidogrelB01AC04severe
- GemfibrozilC10AB04severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pioglitazone in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomActos 30mg tabletsCST Pharma Ltd
- United StatesActosTakeda Pharmaceuticals America, Inc.
- SpainACTOS 30 mg COMPRIMIDOSCheplapharm Arzneimittel Gmbh
- FinlandActosParanova Oy
- NetherlandsActos 30 mg tablet, tablettenCHEPLAPHARM Arzneimittel GmbH
- SwedenActos 30 mg TablettCheplapharm Arzneimittel GmbH
- ItalyACTOSCHEPLAPHARM ARZNEIMITTEL GMBH
- CanadaACH-PIOGLITAZONEACCORD HEALTHCARE INC
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Bulgaria · Pioglitazone Sanovel, Пизона
- Cyprus · Zipion
- Germany · Pioglitazon Aurobindo
- Spain · Pioglitazona Aurovitas, Pioglitazona Cinfa
- United Kingdom (Northern Ireland) · Pioglitazone Brown And Burk Uk Ltd, Pioglitazone Generics
- Greece · Glitact, Raglitan
- Croatia · Novapio, Pioglitazon Pliva
- Iceland · Actos, Pioglitazone Accord
- Italy · Pioglitazone Aurobindo, Pioglitazone Doc Generici
- Liechtenstein · Actos, Pioglitazone Accord
- Latvia · Zipion
- Malta · Novapio
- Netherlands · Pioglitazone Hydrochloride Aurobindo, Pioglitazone Sanovel
- Norway · Actos, Pioglitazone Accord
- Poland · Pioglitazone Bioton
- Portugal · Pioglitazona Atrolex, Pioglitazona Aurovitas
- Sweden · Pioglitazone Holsten
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f74d3bc8-5689-4641-a867-f38f01d8cf3a GET /v1/drugs/f74d3bc8-5689-4641-a867-f38f01d8cf3a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL NOB",
"source": "sukl",
"strength": "30MG",
"pack_size": "56",
"substance": "PIOGLITAZONE HYDROCHLORIDE",
"cz_kod_sukl": "0289312",
"product_type": "CH",
"substance_codes": "16290",
"registration_state": "B",
"registration_number": "18/563/12-C"
}See everything about pioglitazone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.